Sagimet Biosciences Inc. – NASDAQ:SGMT

Sagimet Biosciences stock price today

$7.04
+2.09
+42.51%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sagimet Biosciences stock price monthly change

+48.35%
month

Sagimet Biosciences stock price quarterly change

+48.35%
quarter

Sagimet Biosciences stock price yearly change

-14.97%
year

Sagimet Biosciences key metrics

Market Cap
149.38M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-1.34
Revenue
N/A
EBITDA
-32.74M
Income
-27.91M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sagimet Biosciences stock price history

Sagimet Biosciences stock forecast

Sagimet Biosciences financial statements

Sagimet Biosciences Inc. (NASDAQ:SGMT): Profit margin
Jun 2023 0 -6.78M
Sep 2023 2M -6.35M -317.65%
Dec 2023 0 -8.15M
Mar 2024 0 -6.62M
Sagimet Biosciences Inc. (NASDAQ:SGMT): Analyst Estimates
2025 2M -116.40M -5820.4%
2026 2M -181.28M -9064.47%
  • Analysts Price target

  • Financials & Ratios estimates

Sagimet Biosciences Inc. (NASDAQ:SGMT): Earnings per share (EPS)
2024-03-25 -0.62 -0.78
2024-05-15 -0.41 -0.23
Sagimet Biosciences Inc. (NASDAQ:SGMT): Debt to assets
Jun 2023 21498000 219.91M 1022.94%
Sep 2023 102925000 5.05M 4.91%
Dec 2023 96719000 5.65M 5.85%
Mar 2024 194528000 4.51M 2.32%
Sagimet Biosciences Inc. (NASDAQ:SGMT): Cash Flow
Jun 2023 -5.72M 12.8M -910K
Sep 2023 -3.87M 0 87.21M
Dec 2023 -7.08M -19.62M 3.51M
Mar 2024 -6.20M 3M 104.84M

Sagimet Biosciences alternative data

Sagimet Biosciences Inc. (NASDAQ:SGMT): Employee count
Dec 2023 9
Jan 2024 9
Feb 2024 9
Mar 2024 8
Apr 2024 8
May 2024 8
Jun 2024 8
Jul 2024 8

Sagimet Biosciences other data

Sagimet Biosciences Inc. (NASDAQ:SGMT): Insider trades (number of shares)
Period Buy Sel
Jul 2023 30000 662
Mar 2024 12100 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HAPPEL DAVID director, officer: President & ..
Series A Common Stock 12,100 $5.27 $63,731
Purchase
NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner
Series A Common Stock 30,000 $16 $480,000
Sale
NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner
Series A Common Stock 662 $16 $10,592
Thursday, 14 November 2024
seekingalpha.com
Tuesday, 12 November 2024
prnewswire.com
Friday, 18 October 2024
seekingalpha.com
Friday, 11 October 2024
globenewswire.com
Wednesday, 2 October 2024
zacks.com
Tuesday, 1 October 2024
globenewswire.com
globenewswire.com
Thursday, 12 September 2024
globenewswire.com
Monday, 12 August 2024
247wallst.com
Thursday, 1 August 2024
globenewswire.com
Wednesday, 31 July 2024
seekingalpha.com
Monday, 10 June 2024
globenewswire.com
Thursday, 6 June 2024
globenewswire.com
Monday, 20 May 2024
https://www.defenseworld.net
https://www.defenseworld.net
Thursday, 16 May 2024
globenewswire.com
Wednesday, 15 May 2024
globenewswire.com
Tuesday, 7 May 2024
globenewswire.com
Monday, 6 May 2024
globenewswire.com
Monday, 22 April 2024
globenewswire.com
Wednesday, 27 March 2024
globenewswire.com
Monday, 25 March 2024
globenewswire.com
globenewswire.com
Thursday, 29 February 2024
GlobeNewsWire
Wednesday, 22 November 2023
GlobeNewsWire
  • What's the price of Sagimet Biosciences stock today?

    One share of Sagimet Biosciences stock can currently be purchased for approximately $7.04.

  • When is Sagimet Biosciences's next earnings date?

    Unfortunately, Sagimet Biosciences's (SGMT) next earnings date is currently unknown.

  • Does Sagimet Biosciences pay dividends?

    No, Sagimet Biosciences does not pay dividends.

  • How much money does Sagimet Biosciences make?

    Sagimet Biosciences has a market capitalization of 149.38M. Sagimet Biosciences made a loss 27.88M US dollars in net income (profit) last year or -$0.23 on an earnings per share basis.

  • What is Sagimet Biosciences's stock symbol?

    Sagimet Biosciences Inc. is traded on the NASDAQ under the ticker symbol "SGMT".

  • What is Sagimet Biosciences's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Sagimet Biosciences?

    Shares of Sagimet Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Sagimet Biosciences have?

    As Jul 2024, Sagimet Biosciences employs 8 workers.

  • When Sagimet Biosciences went public?

    Sagimet Biosciences Inc. is publicly traded company for more then 2 years since IPO on 17 Jul 2023.

  • What is Sagimet Biosciences's official website?

    The official website for Sagimet Biosciences is sagimet.com.

  • Where are Sagimet Biosciences's headquarters?

    Sagimet Biosciences is headquartered at 155 Bovet Road, San Mateo, CA.

  • How can i contact Sagimet Biosciences?

    Sagimet Biosciences's mailing address is 155 Bovet Road, San Mateo, CA and company can be reached via phone at +65 05618600.

Sagimet Biosciences company profile:

Sagimet Biosciences Inc.

sagimet.com
Exchange:

NASDAQ

Full time employees:

8

Industry:

Biotechnology

Sector:

Healthcare

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

155 Bovet Road
San Mateo, CA 94402

CIK: 0001400118
ISIN: US7867001049
CUSIP: 786700104